Clinical trials for triple negative breast cancer

 

Trial name

 

Title of clinical trial

 

Hyperlink

 

IMPASSION 131

 

A study of atezolizumab and paclitaxel versus placebo and paclitaxel in participants with previously untreated locally advanced or metastatic triple negative breast cancer.
Open to men & women.

 

Clinical Trials Information

 

CORE

 

A randomised controlled trial, which includes breast, prostate or non-small cell lung primary cancer and extra cranial oligometastases suitable for stereotactic body radiotherapy.

 

Clinical Trials Information

 

B-AHEAD 3

 

A randomised trial of intermittent energy restriction and resistance exercise in women receiving chemotherapy for advanced breast cancer.
Open to women.

 

Clinical Trials Information

 

PIPA

 

A study looking at taselisib and palbociclib for breast cancer with a mutation in the PIK3CA gene that has stopped responding to treatment.
Open to men & women.

 

Clinical Trials Information

 

Plasma Match

 

A trial carrying out plasma based molecular profiling of advanced breast cancer to inform therapeutic choices.
Open to women.

 

Clinical Trials Information

 

IMMU-132-05

 

Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Open to men and women.

 

Clinical Trials Information

 

Impassion-132

 

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Open to men and women.

 

Clinical Trials Information